Clinicians Should Maintain Awareness for KSHV Infection Among Organ Transplant Recipients |
|---|
New Morbitity and Mortality Weekly Report (MMWR) reveals significant increase in reported cases of Kaposi Sarcoma–associated herpesvirus (KSHV) infections and deaths among solid organ transplant recipients in the United States (Jan. 2021-Sept. 2025)—making it one of the most consequential infectious disease outbreaks associated with organ transplantation in the U.S. in the last 20 years. This report underscores the need for enhanced awareness and screening protocols. |
|---|
Key Findings
| ![]() |
|---|
Clinical Implications Given that people who receive solid organ transplants are on immunosuppressive medications, KSHV infections can lead to severe complications and even death. It is important for clinicians to maintain a high index of suspicion for KSHV in transplant recipients, especially when KSHV infection is identified in another recipient or donors have risk factors such as non-medical drug use. Recommendations
Review the full MMWR for a comprehensive understanding of the findings and their implications for clinical practice.
|
|---|
New MMWR on Kaposi Sarcoma–associated herpesvirus (KSHV) investigation reveals one of the most consequential infectious disease outbreaks associated with organ transplantation in the U.S. in the last 20 years. https://www.cdc.gov/mmwr/volumes/75/wr/mm7508a1.htm |
|---|
|
|---|